Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-11-19
1995-02-21
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540222, A61K 31545, C07D50132
Patent
active
RE0348651
ABSTRACT:
Cephemcarboxylic acid esters of the general formula ##STR1## pharmaceutical preparations which are active against bacterial infections, which contain such cephem derivatives, a process for the preparation of the cephem derivatives and the pharmaceutical preparations, and also the use of the cephem derivatives for combating bacterial infections.
REFERENCES:
patent: 4098888 (1978-06-01), Ochiai et al.
patent: 4203899 (1980-05-01), Ochiai et al.
patent: 4205180 (1980-05-01), Ochiai et al.
patent: 4264595 (1981-04-01), Numata et al.
patent: 4278793 (1981-07-01), Durckheimer et al.
patent: 4283396 (1981-08-01), Heymes et al.
patent: 4298606 (1981-11-01), Ochiai et al.
patent: 4355160 (1982-10-01), Ochiai et al.
patent: 4409215 (1983-10-01), Takaya et al.
patent: 4462999 (1984-07-01), Takaya et al.
patent: 4483855 (1984-11-01), Nakao et al.
patent: 4486425 (1984-12-01), Nakao et al.
patent: 4514565 (1985-04-01), Ochiai et al.
patent: 4668783 (1987-05-01), Ochiai et al.
patent: 4904652 (1990-02-01), Takaya et al.
patent: 4912212 (1990-03-01), Ochiai et al.
patent: 4973684 (1990-11-01), Ochiai et al.
patent: 4992431 (1991-03-01), Heymes et al.
patent: 5026695 (1991-06-01), Takaya et al.
patent: 5063224 (1991-11-01), Mosher et al.
Chemical Abstracts vol. 117: 103648 (1992).
Chemical Abstracts, vol. 97, 162705p (1982).
In Vivo Evaluation of Tigemonam, a Novel Oral Monobactam, Junius M. Clark et al., Antimicrobial Agents and Chemotherapy, vol. 31, No. 2, Feb. 1987, pp. 226-229.
Pharmacokinetic and In Vivo Studies with Azithromycin (CP-62,993), a New Macrolide with an Extended Half-Life and Excellent Tissue Distribution, Girard et al., Antimicrobial Agents and Chemotherapy, vol. 31, No. 12, Dec. 1987, pp. 1948-1954.
The Relationships of Absorption Characteristics and Gastrointestinal Side Effects of Oral Antimicrobial Agents, Grossman, Clinical Therapeutics, vol. 13, No. 1, pp. 189-193 (1991).
Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2, Dantzig et al., Biochimica et Biophysica Acta, 1027, pp. 211-217 (1990).
Stereochemical Considerations in Drug Absorption, Disposition and Pharmacokinetics, Hutt, Drug Chirality, 24th and 25th Oct., 1990.
Studies on Orally Active Cephalosporin Esters. IV..sup.1), Miyauchi et al., Chem. Pharm. Bull. 32(12), pp. 3272-3276 (1989).
Studies on Orally Active Cephalosporin Esters. II..sup.1), Miyauchi et al., Chem. Pharm. Bull. 37(9), pp. 2369-2374 (1989.
Synthesis and Mechanisms of Decomposition of Some Cephalosporin Prodrugs, Saab et al., Journal of Pharmaceutical Sciences, vol. 79, No. 9, (1990).
Orally Active 1-(Cyclohexyloxycarbonyloxy)Alkyl Ester Prodrugs of Cefotiam Nishimura et al., The Journal of Antibiotics, vol. XL, No. 1, pp. 81-90 (1986).
Angewandte Chemie, vol. 24, No. 3, Mar. 1985, pp. 180-202.
Pharmacokinetics of FK482, A New Orally Active Cephalosporin, in Animals, Sakamoto et al., The Journal of Antibiotics, vol. XLI, No. 12, pp. 1896-1905 (1988).
Adam Friedhelm
Blumbach Jurgen
Durckheimer Walter
Fischer Gerd
Isert Dieter
Hoechst Aktiengesellschaft
Rizzo Nicholas
LandOfFree
Cephalosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephalosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1921880